In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 28 | Yes |
(E)-N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide
AG-013736; N-methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide
Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-
Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-
N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.98 | 8.98 | -14.29 | 2 | 5 | 0 | 71 | 386.48 | 5 | ↓ |
Ref Reference (pH 7) | 4.05 | 7.14 | -33.97 | 3 | 5 | 1 | 76 | 387.488 | 5 | ↓ |
Mid Mid (pH 6-8) | 4.05 | 7.23 | -34.45 | 3 | 5 | 1 | 76 | 387.488 | 5 | ↓ |
Mid Mid (pH 6-8) | 4.05 | 7.1 | -14.58 | 2 | 5 | 0 | 74 | 386.48 | 5 | ↓ |
Mid Mid (pH 6-8) | 4.05 | 7.19 | -12.1 | 2 | 5 | 0 | 74 | 386.48 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | VEGFR, PDGFR, c-Kit | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 0.25 | 0.48 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 0.25 | 0.48 | Binding ≤ 10μM |
Description | Species |
---|---|
EPHA-mediated growth cone collapse | |
Integrin cell surface interactions | |
Neurophilin interactions with VEGF and VEGFR | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |